Comparison of safety and efficacy of Netarsudil 0.02% and Bimatoprost 0.01% monotherapy and combination therapy in primary open-angle glaucoma and ocular hypertension

Míreanna comhchosúla

• Retrospective Analysis of Switching Bimatoprost 0.01% to Bimatoprost 0.03% in Patients with Various Types of Glaucoma and Ocular Hypertension
  de réir: Xu KM, et al.
  Foilsithe / Cruthaithe: (2022-07-01)
• Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% – an observational switch study
  de réir: Deshpande SS, et al.
  Foilsithe / Cruthaithe: (2017-07-01)
• Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications
  de réir: Shen J, et al.
  Foilsithe / Cruthaithe: (2017-09-01)
• A comparative study of 0.4% ripasudil, 0.02% netarsudil, and 0.5% timolol in combination with 0.005% latanoprost in the medical management of primary open-angle glaucoma or ocular hypertension
  de réir: Tirupati Nath, et al.
  Foilsithe / Cruthaithe: (2024-05-01)
• Netarsudil-associated reversible “honeycomb” pattern corneal epithelial edema
  de réir: Sathyan Parthasarathi, et al.
  Foilsithe / Cruthaithe: (2023-01-01)